1. Home
  2. VECO vs NAMS Comparison

VECO vs NAMS Comparison

Compare VECO & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$57.78

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$34.66

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
NAMS
Founded
1945
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
VECO
NAMS
Price
$57.78
$34.66
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$27.25
$46.75
AVG Volume (30 Days)
1.9M
1.1M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$664,294,000.00
N/A
Revenue This Year
$16.39
$17.96
Revenue Next Year
$12.40
$540.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.29
$20.53
52 Week High
$86.63
$42.21

Technical Indicators

Market Signals
Indicator
VECO
NAMS
Relative Strength Index (RSI) 40.46 61.14
Support Level $53.50 $33.83
Resistance Level $64.92 $37.27
Average True Range (ATR) 6.26 1.53
MACD -1.97 0.57
Stochastic Oscillator 3.40 79.16

Price Performance

Historical Comparison
VECO
NAMS

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The maximum of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: